Cargando…
Targeting IRAK1 in T-Cell acute lymphoblastic leukemia
T-cell acute lymphoblastic leukemia (T-ALL) represents expansion of cells arrested at specific stages of thymic development with the underlying genetic abnormality often determining the stage of maturation arrest. Although their outcome has been improved with current therapy, survival rates remain o...
Autores principales: | Dussiau, Charles, Trinquand, Amélie, Lhermitte, Ludovic, Latiri, Mehdi, Simonin, Mathieu, Cieslak, Agata, Bedjaoui, Nawel, Villarèse, Patrick, Verhoeyen, Els, Dombret, Hervé, Ifrah, Norbert, Macintyre, Elizabeth, Asnafi, Vahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662467/ https://www.ncbi.nlm.nih.gov/pubmed/26068967 |
Ejemplares similares
-
P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
por: Dourthe, Marie-Emilie, et al.
Publicado: (2023) -
RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangement
por: Cieslak, Agata, et al.
Publicado: (2014) -
RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangement
por: Cieslak, Agata, et al.
Publicado: (2014) -
Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia
por: Touzart, Aurore, et al.
Publicado: (2020) -
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
por: Balducci, Estelle, et al.
Publicado: (2023)